Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer

BACKGROUND: Patients with liver metastatic colorectal cancer (mCRC) often benefit from receiving (90)Y-microsphere radioembolization (RE) administered via the hepatic arteries. Prior to delivery of liver-directed radiation, standard laboratory tests may assist in improving outcome by identifying cor...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Gastrointest Oncol
Главные авторы: Kennedy, Andrew S., Ball, David, Cohen, Steven J., Cohn, Michael, Coldwell, Douglas M., Drooz, Alain, Ehrenwald, Edward, Kanani, Samir, Moeslein, Fred M., Nutting, Charles W., Putnam, Samuel G., Rose, Steven C., Savin, Michael, Schirm, Sabine, Sharma, Navesh K., Wang, Eric
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334043/
https://ncbi.nlm.nih.gov/pubmed/28280611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.01.03
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы